FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1863-1871 June 17, 1999 Number 24 Next

	Full Text PDF Editorial by Jaffe, H. W. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Infection with human herpesvirus 8 (HHV-8) has been consistently linked to Kaposi's sarcoma, but its mode of transmission, association with other cancers, and interaction with the human immunodeficiency virus type 1 (HIV-1) are largely unknown.

Methods Between January 1992 and December 1997, we interviewed 3591 black patients with cancer in Johannesburg and Soweto, South Africa. Blood was tested for antibodies against HIV-1 and HHV-8 in 3344 of the patients. Antibodies against HHV-8 were detected with an indirect immunofluorescence assay. The intensity of the fluorescent signal correlated well with the titers of antibodies (P<0.001). The relations among the presence of anti–HHV-8 antibodies, sociodemographic and behavioral factors, type of cancer, and the presence or absence of coexistent HIV-1 infection were examined with the use of unconditional logistic-regression models.

Results Among the 3293 subjects with cancers other than Kaposi's sarcoma, the standardized seroprevalence of antibodies against HHV-8 was 32 percent, which did not differ significantly from the standardized seroprevalence among black blood donors. Among these 3293 patients, the prevalence of antibodies against HHV-8 increased with increasing age (P<0.001) and an increasing number of sexual partners (P=0.05) and decreased with increasing years of education (P=0.007); it was not strongly associated with HIV-1 infection. Anti–HHV-8 antibodies were more frequent among black than white blood donors (P<0.001). Among the 51 patients with Kaposi's sarcoma, the standardized seroprevalence of antibodies against HHV-8 was 83 percent, significantly higher than the prevalence among those without Kaposi's sarcoma (P<0.001). For 16 other specific types of cancer, including multiple myeloma (108 cases) and prostate cancer (202 cases), the variation in the standardized seroprevalence of antibodies against HHV-8 was not remarkable. At a given intensity of fluorescence of anti–HHV-8 antibodies, Kaposi's sarcoma was more frequent among HIV-1–positive patients than among those who were HIV-1–negative (P<0.001).

Conclusions Among black patients with cancer in South Africa, the seroprevalence of anti–HHV-8 antibodies is high and is specifically associated with Kaposi's sarcoma, particularly at high titers.

Source Information

From the South African Cancer Epidemiology Unit, National Cancer Registry (F.S., H.C., R.P.-N.), and the Departments of Anatomical Pathology (F.S., H.C., R.P.-N.) and Serology (U.J.), South African Institute for Medical Research — both in Johannesburg; the Imperial Cancer Research Fund Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom (V.B., R.N., G.R., D. Bull); and the Departments of Oncology and Molecular Pathology, University College London, London (D. Bourboulia, D.W., C.B., R.W.). Other authors were Moosa Patel, F.C.P.(S.A.), M.Med., Paul Ruff, M.B., B.Ch., M.Med., Werner R. Bezwoda, F.C.P., Ph.D., and Edna Retter, L.M.C. (University of the Witwatersrand, Johannesburg, South Africa); and Martin Hale, M.B., Ch.B., F.C.Path. (South African Institute for Medical Research, Johannesburg).

Address reprint requests to Dr. Sitas at the South African Institute for Medical Research, P.O. Box 1038, Johannesburg 2000, South Africa, or at freddys{at}mail.saimr.wits.ac.za.

Full Text of this Article

This article has been cited by other articles:

• Sutcliffe, S., Giovannucci, E., Gaydos, C. A., Viscidi, R. P., Jenkins, F. J., Zenilman, J. M., Jacobson, L. P., De Marzo, A. M., Willett, W. C., Platz, E. A. (2007). Plasma Antibodies against Chlamydia trachomatis, Human Papillomavirus, and Human Herpesvirus Type 8 in Relation to Prostate Cancer: A Prospective Study. Cancer Epidemiol. Biomarkers Prev. 16: 1573-1580 [Abstract] [Full Text]  
• Teo, C.G. (2006). Conceptual Emergence of Human Herpesvirus 8 (Kaposi's Sarcoma-associated Herpesvirus) as an Oral Herpesvirus. Adv. Dent. Res. 19: 85-90 [Abstract] [Full Text]  
• Palapattu, G. S., Sutcliffe, S., Bastian, P. J., Platz, E. A., De Marzo, A. M., Isaacs, W. B., Nelson, W. G. (2005). Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 26: 1170-1181 [Abstract] [Full Text]  
• Moosa, M.R. (2005). Kaposi's sarcoma in kidney transplant recipients: a 23-year experience. QJM 98: 205-214 [Abstract] [Full Text]  
• Lu, C., Zeng, Y., Huang, Z., Huang, L., Qian, C., Tang, G., Qin, D. (2005). Human Herpesvirus 6 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus. Am. J. Pathol. 166: 173-183 [Abstract] [Full Text]  
• Stebbing, J., Gazzard, B., Mandalia, S., Teague, A., Waterston, A., Marvin, V., Nelson, M., Bower, M. (2004). Antiretroviral Treatment Regimens and Immune Parameters in the Prevention of Systemic AIDS-Related Non-Hodgkin's Lymphoma. JCO 22: 2177-2183 [Abstract] [Full Text]  
• Haque, N. S., Fallon, J. T., Pan, J. J., Taubman, M. B., Harpel, P. C. (2004). Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion. Blood 103: 1296-1304 [Abstract] [Full Text]  
• Dourmishev, L. A., Dourmishev, A. L., Palmeri, D., Schwartz, R. A., Lukac, D. M. (2003). Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis. Microbiol. Mol. Biol. Rev. 67: 175-212 [Abstract] [Full Text]  
• Plancoulaine, S., Abel, L., van Beveren, M., Gessain, A. (2002). High Titers of Anti-Human Herpesvirus 8 Antibodies in Elderly Males in an Endemic Population. JNCI J Natl Cancer Inst 94: 1333-1335 [Abstract] [Full Text]  
• Malnati, M., Broccolo, F., Nozza, S., Sarmati, L., Ghezzi, S., Locatelli, G., Delfanti, F., Capiluppi, B., Careddu, A., Andreoni, M., Monini, P., Poli, G., Lazzarin, A., Lusso, P., Tambussi, G. (2002). Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. Blood 100: 1575-1578 [Abstract] [Full Text]  
• Ablashi, D. V., Chatlynne, L. G., Whitman, J. E. Jr., Cesarman, E. (2002). Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases. Clin. Microbiol. Rev. 15: 439-464 [Abstract] [Full Text]  
• Fakhari, F. D., Dittmer, D. P. (2002). Charting Latency Transcripts in Kaposi's Sarcoma-Associated Herpesvirus by Whole-Genome Real-Time Quantitative PCR. J. Virol. 76: 6213-6223 [Abstract] [Full Text]  
• Tedeschi, R., Enbom, M., Bidoli, E., Linde, A., De Paoli, P., Dillner, J. (2001). Viral Load of Human Herpesvirus 8 in Peripheral Blood of Human Immunodeficiency Virus-Infected Patients with Kaposi's Sarcoma. J. Clin. Microbiol. 39: 4269-4273 [Abstract] [Full Text]  
• Davidovici, B., Karakis, I., Bourboulia, D., Ariad, S., Zong, J.-C., Benharroch, D., Dupin, N., Weiss, R., Hayward, G., Sarov, B., Boshoff, C. (2001). Seroepidemiology and Molecular Epidemiology of Kaposi's Sarcoma-Associated Herpesvirus Among Jewish Population Groups in Israel. JNCI J Natl Cancer Inst 93: 194-202 [Abstract] [Full Text]  
• Haque, N. S., Fallon, J. T., Taubman, M. B., Harpel, P. C. (2001). The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. Blood 97: 39-45 [Abstract] [Full Text]  
• Sitas, F., Newton, R. (2000). Kaposi's Sarcoma in South Africa. J Natl Cancer Inst Monogr 2000: 1-4 [Abstract] [Full Text]  
• Caselli, D., Klersy, C., de Martino, M., Gabiano, C., Galli, L., Tovo, P. A., Arico, M. (2000). Human Immunodeficiency Virus-Related Cancer in Children: Incidence and Treatment Outcome--Report of the Italian Register. JCO 18: 3854-3861 [Abstract] [Full Text]  
• Pauk, J., Huang, M.-L., Brodie, S. J., Wald, A., Koelle, D. M., Schacker, T., Celum, C., Selke, S., Corey, L. (2000). Mucosal Shedding of Human Herpesvirus 8 in Men. NEJM 343: 1369-1377 [Abstract] [Full Text]  
• Alagiozoglou, L., Sitas, F., Morris, L. (2000). Phylogenetic analysis of human herpesvirus-8 in South Africa and identification of a novel subgroup. J. Gen. Virol. 81: 2029-2038 [Abstract] [Full Text]  
• Hussein, M. M., Mooij, J. M., Roujouleh, H. M. (2000). Regression of post-transplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate mofetil instead. Nephrol Dial Transplant 15: 1103-1104 [Full Text]  
• Weiss, R., Boshoff, C. (2000). Addressing Controversies Over Kaposi's Sarcoma. JNCI J Natl Cancer Inst 92: 677-679 [Full Text]  
• Antman, K., Chang, Y. (2000). Kaposi's Sarcoma. NEJM 342: 1027-1038 [Full Text]  
• Aboulafia, D. M. (2000). The Epidemiologic, Pathologic, and Clinical Features of AIDS-Associated Pulmonary Kaposi’s Sarcoma. Chest 117: 1128-1145 [Abstract] [Full Text]  
• Dupin, N., Diss, T. L., Kellam, P., Tulliez, M., Du, M.-Q., Sicard, D., Weiss, R. A., Isaacson, P. G., Boshoff, C. (2000). HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95: 1406-1412 [Abstract] [Full Text]  
• Engels, E. A., Eastman, H., Ablashi, D. V., Wilks, R. J., Braham, J., Manns, A. (1999). Risk of Transfusion-Associated Transmission of Human Herpesvirus 8. JNCI J Natl Cancer Inst 91: 1773-1775 [Full Text]  
• Campbell, T. B., Borok, M., Gwanzura, L., Bourboulia, D., Boshoff, C., Sitas, F. (1999). HHV-8 Peripheral-Blood Viral Load and the Titer of Antibodies against HHV-8. NEJM 341: 1241-1242 [Full Text]  
• Beral, V., Newton, R., Sitas, F. (1999). Human Herpesvirus 8 and Cancer. JNCI J Natl Cancer Inst 91: 1440-1441 [Full Text]  
• Jaffe, H. W., Pellett, P. E. (1999). Human Herpesvirus 8 and Kaposi's Sarcoma -- Some Answers, More Questions. NEJM 340: 1912-1913 [Full Text]  
• Sitas, F., Newton, R., Boshoff, C. (1999). Increasing Probability of Mother-to-Child Transmission of HHV-8 with Increasing Maternal Antibody Titer for HHV-8. NEJM 340: 1923-1923 [Full Text]